We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
+16.55%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.43B
AUM Growth
+$203M
Cap. Flow
+$23.3M
Cap. Flow %
1.63%
Top 10 Hldgs %
47.17%
Holding
186
New
16
Increased
59
Reduced
61
Closed
5

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.7M
2
ORCL icon
Oracle
ORCL
+$5.36M
3
PLD icon
Prologis
PLD
+$4.68M
4
OKTA icon
Okta
OKTA
+$3.46M
5
AEP icon
American Electric Power
AEP
+$2.54M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$4.32M
2
TROW icon
T. Rowe Price
TROW
+$3.96M
3
AAPL icon
Apple
AAPL
+$3.38M
4
HAS icon
Hasbro
HAS
+$2.96M
5
RTX icon
RTX Corp
RTX
+$2.86M

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.24%
2 Technology 16.25%
3 Healthcare 13.1%
4 Financials 10.83%
5 Consumer Discretionary 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NLY icon
176
Annaly Capital Management
NLY
$17.2B
$190K 0.01%
+7,250
New +$179K
SWN
177
DELISTED
Southwestern Energy Company
SWN
$28K ﹤0.01%
11,100
– –
SLB icon
178
SLB Ltd
SLB
$73B
– –
-11,385
Closed -$154K
SNY icon
179
Sanofi
SNY
$103B
– –
-98,900
Closed -$4.32M
VFC icon
180
VF Corp
VFC
$5.87B
– –
-20,400
Closed -$1.1M
AGN
181
DELISTED
Allergan Inc
AGN
– –
-2,000
Closed -$354K
4 5 6 7
8

Similar funds

HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
MIM
Marco Investment Management Atlanta, Georgia $1.33B AUM 32.43% 1-Year Est. Return
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return

Cullinan Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Cullinan Associates held 186 positions worth $1.43B, up 17% from $1.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Cullinan Associates's Q2 2020 filing shows 16 new, 59 increased, 61 reduced and 5 closed positions. Its largest new stake was Okta: 20,400 shares worth $4.08M. The largest sale was Sanofi, an estimated $4.32M.

By sector, the portfolio is most concentrated in Consumer Staples at 33% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q2 2020 buy was Okta: 20,400 shares worth $4.08M.
  • Cullinan Associates added most to Amgen in Q2 2020, an estimated $28.7M increase.
  • Cullinan Associates's biggest Q2 2020 reduction was T. Rowe Price, cutting an estimated $3.96M.
  • Cullinan Associates fully exited Sanofi in Q2 2020, selling an estimated $4.32M.
  • Cullinan Associates's ten largest holdings make up 47% of its $1.43B portfolio in Q2 2020.
  • Cullinan Associates opened 16 new positions and closed 5 in Q2 2020.
  • Cullinan Associates's portfolio value rose 17% quarter-over-quarter to $1.43B.

Based on Cullinan Associates's 13F filing for Q2 2020, filed 7 Jul 2020.